Amit Verma: Clinical Trials

1 trial sponsored by Amit Verma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Terminated 1

Follow Amit Verma: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase II Study Of Imtox-25 In Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma
IMTOX-25 - Adult T Cell Leukemia, Adult T Cell Lymphoma
Phase 2TerminatedAmit Verma12010-09-012023-06-09

Conditions studied

Leukemia (1)  ·  Lymphoma (1)  ·  Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (1)

Interventions

RFT5-SMPT-dgA immunotoxin (1)

Countries

United States (1)

Top investigators

Samir Parekh, MD (1)